Grant-Huerta Yanina
- SEC CIK
- 0002064348
In the past year, 3 open-market sale filings worth $56.5K and no purchases.
Current role at each company
- IMA ImageneBio, Inc.Chief Financial Officeras of Aug 17, 2026
- ATRA Atara Biotherapeutics, Inc.Chief Accounting Officeras of May 20, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $56.5K
- 3 filings
- Net
- −$56.5K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Grant-Huerta Yanina as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ATRA Atara Biotherapeutics, Inc.
Chief Accounting Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 (view filing) | May 18 | 2 days | Grant-Huerta YaninaChief Accounting Officer | SSale | −2.41K | $9.13 | −$22.0K | −4.6%49.6K after | |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Grant-Huerta YaninaChief Accounting Officer | SSale | −2.10K | $5.08 | −$10.7K | −6.2%31.8K after | 4 lots |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Grant-Huerta YaninaChief Accounting Officer | SSale | −1.80K | $13.19 | −$23.8K | −5.1%33.5K after | 3 lots |
| Aug 20, 2025 (view filing) | Aug 18 | 2 days | Grant-Huerta YaninaChief Accounting Officer | SSale | −1.81K | $11.61 | −$21.0K | −4.9%35.3K after | 3 lots |
| May 20, 2025 (view filing) | May 16 | 4 days | Grant-Huerta YaninaChief Accounting Officer | SSale | −2.22K | $6.76 | −$15.0K | −5.6%37.1K after |